Teradyne Gains 130% YTD: Should You Hold or Fold the Stock?

Teradyne reported record Q2 2026 memory revenue of $212 million, its third consecutive quarter above $200 million, and memory book-to-bill exceeded 2; management expects 2026 memory-test TAM to be more than 40% larger than in 2025. Q3 2026 revenue guidance is $1.20-$1.30 billion against a $1.27 billion consensus, while non-GAAP EPS guidance of $1.85-$2.15 brackets the $2.04 consensus. AI-driven demand and the Magnum E2 launch support growth, but competition, customer concentration, margin pressure and a forward P/S of 11.93x versus 6.18x for the sector underpin the article's cautious Zacks Hold view.

Analysis

Teradyne’s key debate is conversion, not demand: elevated memory bookings can support near-term sales while a richer memory mix, customer concentration, and program timing weaken incremental margins or make deliveries lumpy. A book-to-bill above 2 is a leading indicator, not proof of durable utilization or earnings power. The new platform may help defend qualification slots, but product capability alone does not establish share gains; customer awards and gross-margin contribution need verification.

The comparison with Vertiv and KLA is not a clean competitive read-through: cooling/power infrastructure and process control are different exposures from semiconductor test. Cohu’s HBM inspection opportunity is adjacent to, rather than necessarily a direct substitute for, Teradyne’s test systems. The broader second-order risk is that AI spending remains strong but shifts among bottlenecks, leaving individual equipment vendors exposed to order timing and customer concentration.

Near term, the guidance framing offers limited incremental evidence of an estimate reset: the revenue consensus is within the company’s range and toward its upper half. After a large rerating, execution has to sustain both growth and margins. Over 1–3 months, watch quarterly memory revenue conversion, gross-margin direction, and customer/program commentary; over 6–18 months, HBM and interface transitions could expand test intensity, but the cycle remains exposed to memory capex discipline. The thesis weakens if margins stabilize while memory demand converts to shipments; it strengthens if revenue growth comes with margin deterioration or delayed programs.

Key Decisions for Investors

• Avoid chasing TER on AI demand alone. For existing exposure, consider reducing position size or hedging into strength; a 1–3 month bear put spread is a defined-risk expression only if implied volatility leaves acceptable premium at risk. Do not set strikes without current price and options data.
• Before adding TER, verify memory-segment gross-margin contribution, shipment conversion from bookings, and customer/program concentration in the next results. Sustained memory growth with stable consolidated margins would falsify the cautious thesis; missed shipments or margin compression would confirm it.
• Keep COHU on a watchlist rather than treating it as an automatic TER short: seek evidence that HBM inspection wins are converting into reported revenue and repeat production deployments. The article does not establish a comparable valuation or earnings sensitivity for a pair trade.
• Do not use VRT or KLAC as direct hedges for TER solely on the cited competitive framing; their business exposures differ. Reassess only if relative earnings revisions or valuation data support a sector-neutral pair.